Cargando…
Analysis of m6A-related signatures associated with the tumor immune microenvironment and predict survival in acute myeloid leukemia
BACKGROUND: Most previous studies have focused on the intrinsic carcinogenic pathways of tumors; however, little is known about the potential role of N6-methyladenosine (m6A) methylation in the tumor immune microenvironment (TIME). To better diagnose and treat acute myeloid leukemia (AML), we sought...
Autores principales: | Yuan, Shushu, Cong, Zhirong, Ji, Jiali, Zhu, Li, Jiang, Qi, Zhou, Ying, Shen, Qian, Damiani, Daniela, Xu, Xiaohong, Li, Bingzong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469131/ https://www.ncbi.nlm.nih.gov/pubmed/36111007 http://dx.doi.org/10.21037/atm-22-3858 |
Ejemplares similares
-
Checkpoint Inhibitors in Acute Myeloid Leukemia
por: Damiani, Daniela, et al.
Publicado: (2023) -
The pyroptosis-related gene signature predicts prognosis and reveals characterization of the tumor immune microenvironment in acute myeloid leukemia
por: Zhou, Tao, et al.
Publicado: (2022) -
m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia
por: Xu, Zi-Jun, et al.
Publicado: (2022) -
m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia
por: Zhong, Fangmin, et al.
Publicado: (2022) -
Identification of survival-related alternative splicing signatures in acute myeloid leukemia
por: Zhang, Biyu, et al.
Publicado: (2021)